Posted by AGORACOM-JC
at 7:33 AM on Wednesday, December 9th, 2020
–Safe Space Technology™–
TORONTO , Dec. 9, 2020 – Kontrol Energy Corp. ( CSE: KNR ) ( OTCQB: KNRLF ) ( FSE: 1K8 ) (” Kontrol ” or ” Company “) is pleased to announce that it will be hosting a webinar presentation for investors, analysts and media for its Covid-19 detection technology (“BioCloud analyzer” or “BioCloud”). The purpose of the presentation is to provide an operating demonstration and take questions from the audience.
“Following the filing of our patent applications we are excited to demonstrate how the BioCloud technology operates and share that with the public,” says Paul Ghezzi , CEO Kontrol. “We will be providing a demonstration of BioCloud and access to the inner workings of the technology.”
As previously announced on November 30, 2020 , Kontrol has filed the following four patent applications for its BioCloud technology and the Company is pleased to provide the patent references:
UNITED STATES : Application No. 17/105,793 SYSTEM AND METHOD FOR DETECTING AIRBORNE PATHOGENS
UNITED STATES : Application No. 17/105,813 SYSTEM AND METHOD FOR OPTICAL DETECTION OF PATHOGENS
UNITED STATES : Application No. 17/105,804 COLLECTION CHAMBER FOR AN AIR SAMPLING SYSTEM
CANADA SYSTEM AND METHOD FOR DETECTING AIRBORNE PATHOGENS
Title:
Kontrol to Host BioCloud Technology Presentation for Investors, Analysts and Media
Event Date:
Thursday, December 17, 2020 – 4:30 PM Eastern Time
Presentation Type:
Audio with Presenter Controlled Slides and Teleconference
BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, offices, retirement homes, hospitals, mass transportation and others.
Additional information about Kontrol BioCloud can be found on its website at www.kontrolbiocloud.com
BioCloud is an air quality technology and not a medical device. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus). Safe Space Technology is a Kontrol Trademark.
About Kontrol Energy
Kontrol Energy Corp., a Canadian public company, is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol Energy provides a combination of software, hardware, and service solutions to its customers to improve energy management, air quality and continuous emission monitoring.
Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com
Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.
Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.
However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.
Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.
Posted by AGORACOM-JC
at 7:27 AM on Wednesday, December 9th, 2020
VANCOUVER, British Columbia, Dec. 09, 2020 — Loop Insights Inc. (MTRX:TSXV) (RACMF:OTCQB) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement, and automated venue tracing to the brick and mortar space, is pleased to announce the signing of a Memorandum Of Understanding (“MOU”) with SimpliFlying, the world’s leading aviation marketing consulting firm, to support specific near-term opportunities with world renown resorts, national tourism boards, major airlines, airports, cruise ships, and ports.
As a result of this success, existing discussions have significantly advanced with the following near-term Travel Bubble opportunities:
NATIONAL TOURISM BOARDS – Dominican Tourism, Cayman Islands Tourism, Bahamas Tourism, Jamaican Tourism, and Turks & Caicos Tourism Boards.
WORLD RENOWN RESORTS – Iberostar, Bahia Principe, and Hyatt Resorts.
Today’s partnership with SimpliFlying now accelerates the possibility for Loop to truly deliver Travel Bubble solutions on a global basis. With Empower Clinics already delivering diverse and dynamic testing solutions capable of processing thousands of tests per day from its world-class laboratory in Dallas, SimpliFlying provides the final piece that connects international airline carriers, airports, cruise lines, and ports that rely on SimpliFlying to provide them with the necessary solution providers, procedures, and protocols.
Loop Insights CEO Rob Anson stated “This partnership is a very important and powerful next step to accelerate Loop’s potential growth. With the Company’s recent launch of its first live venue events, with the whole world watching, including world-renown venues and hospitality companies, Loop hit it out of the park and provided the world with the empirical data necessary to demonstrate our bubble solution is nothing short of world-class. By adding the direct integration with Empower’s diverse testing capabilities and SimpliFlying’s network of large-scale customer projects, we have now commenced significant discussions surrounding travel bubble opportunities with some of North America’s largest airlines, resort operators, venues, and hospitality groups globally. We anticipate this new revenue stream may be significant for the Company as we progress these opportunities in 2021.”
SIMPLIFLYING IS A TRUSTED NAME TO AIRLINES, AIRPORTS, AND HOTEL GROUPS
SimpliFlying has been consulting to airlines for over a decade and is one of the largest in the world, having worked with over 100 airlines, OEMs, and airports globally with clients that include American Airlines, Turkish Airlines, LATAM Airlines, Airbus, Boeing, Bombardier, and Toronto Pearson Airport.
SimpliFlying also solves complex operational issues facing the airline and tourism industry, working with large hotel groups such as Intercontinental and others.
SIMPLIFLYING LAUNCH OF “SIMPLITESTED” RECEIVES EARLY PRAISE AS ONE OF THE MOST COMPREHENSIVE APPROACHES SO FAR
With the Coronavirus Pandemic wreaking havoc on the global airline and tourism industry, the work of SimpliFlying has become more important than ever in helping to solve how airlines, airports, cruise lines, hotels, and tourism will safely get back to operations. SimpliFlying is working closely with major international airlines and major Canadian airlines on “Travel Bubbles” and “Tourism Bubbles” that involve testing and tracing protocols throughout the travel supply chain.
To this end, SimpliFlying has just launched SimpliTested to highlight and support the needs of key industries around the globe, in partnership with FDA and CE-approved testing providers, reliable labs, and cutting edge exposure notification apps. The initiative has already received early praise from the media:
Shashank Nigam, Founder & CEO of SimpliFlying stated “The travel industry needs a consistent testing standard that is accurate, affordable and easy to self-administer, with reliable contact tracing. The SimpliTested solution disrupts and drastically improves COVID testing for travel in partnership with Empower Clinics and Loop Insights. Testing can be comfortable and contact tracing built-in to ensure the risk of community exposure is severely restricted. This instantly makes it more appealing to the average traveller, airlines, resorts, and the local tourism authorities.”
Steven McAuley, Chairman, and CEO of Empower stated “The prospect of vaccines becoming available will not diminish the need for comprehensive solutions for testing, contact tracing and strategic operational changes to so many industry and society processes and protocols. Loop Insights, SimpliFlying, and Empower’s testing products and lab capabilities represent exactly what is needed to get our economy working again. Loop Insights’ contact tracing solution is proven, effective and ties together data and workflow. SimpliFlying with its deep connections to airlines, airports, tourism and hospitality provide the strategic design of how our solutions must work together ensuring precise new workflows are implemented balancing health & safety with the most basic functional needs of travellers and operators.”
SimpliFlying is the world’s leading aviation marketing consulting firm, yet we behave like an agile startup. Our team is 100% remote-based in Singapore, Spain, UK, and Canada – meaning we can provide airlines with a global and a 24/7 presence. Since 2009, we have not only worked with an enviable list of aviation brands but also built a unique work culture that appeals to the disruptors in the industry. Our team is young, energetic, and brimming with ideas on how to make airlines remarkable. These are ideas based on over ten years of working with over 100 aviation firms and analyzing hundreds of aviation marketing campaigns monthly.
About Empower
Empower provides body and mind wellness for more than 165,000 patients through its clinics in the United States, a telemedicine platform, and a world-class medical diagnostics laboratory in Texas. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across the U.S. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.
About Loop Insights
Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia. Loop’s products and services are backed by Amazon’s Partner Network.
This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Tags: AI, Amazon, artificial intelligence, Big data, covid19, Covid19 tracing, CSE, Fobi, internet of things Posted in Empower Clinics Inc., Loop Insights Inc. | Comments Off on Loop Insights $MTRX.ca $RACMF and Empower Clinics $CBDT.ca $EPWCF “Travel Bubble” Solution For Global Travel Industry Partner With SimpliFlying, World’s Leading Aviation Marketing Consulting Firm, To Support Specific Near Term Opportunities With World Renown Resorts, National Tourism Boards, Major Airlines, Airports, Cruise Ships, and Ports
Posted by AGORACOM-JC
at 7:21 AM on Wednesday, December 9th, 2020
Announced a partnership with the Babe Ruth League, one of the largest youth baseball and softball organizations in the United States, serving more than 1,000,000 players in over 11,000 leagues across the country.
Through the partnership, Binovi becomes the Official Provider of Health Programming for Babe Ruth League, with a curriculum designed to improve vision and cognitive performance among its players, organizers, coaches, and umpires.
Toronto – December 9, 2020 –Binovi Technologies Corp. (Binovi) (TSXV:VISN)I(OTC:BNVIF)|(GR:2EYA) is proud to announce a partnership with the Babe Ruth League, one of the largest youth baseball and softball organizations in the United States, serving more than 1,000,000 players in over 11,000 leagues across the country. Through the partnership, Binovi becomes the Official Provider of Health Programming for Babe Ruth League, with a curriculum designed to improve vision and cognitive performance among its players, organizers, coaches, and umpires.
Binovi will provide Babe Ruth League with vision screening, therapeutic and performance products, and services designed to increase awareness of, and treat, vision-related deficiencies. The overall curriculum, which is created and vetted with best-in-class optometry professionals and athletes, will help players, referees, and volunteers improve key vision-related skills and overall performance on and off the field.
Babe Ruth League, Inc. will also work with Binovi to recognize and correct vision-related impairments using Binovi’s products. Further, for those that need increased therapeutic resources, Binovi will provide referrals through its network of trained vision care professionals across the country.
“From a performance standpoint, this partnership is a natural extension of our prior baseball initiatives with such trainers as Justin Stone, the Director of Hitting for the Chicago Cubs and President of Elite Baseball Training, and with the Professional Baseball Athletic Trainers Society,” said Tania Archer, Head of Commercialization and Strategic Partnerships for Binovi. “It is only natural that we deliver our breakthrough performance technologies to children and teenage players who can benefit from our products and services from an earlier age, not only on the field, but in the classroom as well. We commend Babe Ruth League for their forward-thinking vision to incorporate vision screening and our professional network of optometrists, giving the league’s players, coaches, and umpires a complimentary check-up for potential impairments.”
“We’re proud of our relationship with Binovi to increase the health, safety, and performance of our players and volunteers through the Binovi Platform,” said Steven Tellefsen, President and CEO, Babe Ruth League . “Anyone who has ever tried to hit a baseball understands the visual coordination required to do so. In addition to the performance aspects, we’re excited to bring an added layer of health screening to our leagues; Binovi’s resources are an important addition to our vision for Babe Ruth League moving forward, and we look forward to delivering performance gains while promoting greater vision health.”
Binovi products and services are already used by professional sports training centers, professional sports teams, the Professional Baseball Athletic Trainers Society, and as a resource to increase the neuro-visual performance of professional, collegiate, and amateur players alike.
“Much of our work to date has been with the highest-performing athletes in the form of professional baseball, basketball, hockey, and soccer players, among many others,” said Adam Cegielski, CEO of Binovi . “Working with professionals as adults helps them hone their already-impressive skills, but we believe even greater gains can be made by addressing vision issues at an earlier age. With children, there are not only performance implications to our involvement, but also general safety, health, and development implications to healthy vision. I’d be remiss if I didn’t at least make reference to the fact that we are eager to help the umpires in baseball with their vision, so everybody wins in this partnership.”
This partnership represents a continued focus for the company on sports at the amateur/youth and professional levels. Vision health and neurovisual performance issues are often first manifested or discovered through issues on the field, and being able to address these issues at such an early state is a key factor in overall improved performance, both on the field and off.
Babe Ruth League , Inc., a non-profit, educational organization, named after one of the greatest baseball players of all time – George Herman “Babe” Ruth – has come a long way since its modest start over 70 years ago. The Babe Ruth League, Inc. programs above all, are of, by and for youth. Its mission is to make better citizens through proper supervision of regulation competitive baseball and softball in addition to promoting mental and physical development. In adopting rules, in establishing standards and in all planning, the primary consideration is what is best for the participants. For more information, please visit BabeRuthLeague.org .
About Binovi Connect
Binovi is digitizing the delivery of healthcare by providing users access to all points of their individual performance from their phone, tablet or desktop computer. Designed for vision optimization and the enhancement of skills related to cognitive performance, Binovi provides measurable results in less time, and with less effort. As a SAAS based solution, the Binovi Connect App is supported by specialized expert knowledge, unique data insights and supporting hardware to deliver customized, one-on-one cognitive training and learning protocols ideal for K-12 Students, Vision Care Specialists, and Sports Performance testing and training. Binovi is currently used in over 20 countries.
Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Posted by AGORACOM-JC
at 6:10 PM on Tuesday, December 8th, 2020
Understanding the world of Photonics isn’t the easiest thing small cap investors have had to understand. In fact, it may be the very hardest thing they’ve ever had to understand. However, given the fact we are the very reason current photonics devices aren’t living up to snuff trying to keep up with our surfing, streaming, binging and zooming – you start to see why understanding photonics and POET Technologies could open up investors to a whole new world.
We went beyond the press release with POET management to discuss the launch of their LightBar solution for data centers. They did a great job explaining it in terms that are both compelling yet understandable.
Before watching this video, here is some important background information.
Photonics are critical to the next phase of semiconductor development. Semiconductors are an essential component of every electronic device on the planet.
Photonic devices create, detect and manipulate light. Laser generated light is fundamental to sensing, computing, data and telecommunications, which require the fastest transfer of data possible
For example – the biggest trends in computing today:
Cloud Computing
Artificial Intelligence
5G and Edge
HERE IS THE PROBLEM
Making photonics devices that are reliable is expensive in terms of both capital and labor.
Cost declines have not kept up with Moore’s Law, with most photonics devices built one at a time – and multiple different components must be able to interconnect seamlessly without constant testing.
The Result? Integration of components at wafer-scale has not been fully implemented even by the largest companies working for the past 20 years ….. UNTIL NOW
POET has developed a unique, disruptive and differentiating new entry into photonics markets.
The POET Optical Interposer™ Platform – patented photonics integration platform that enables lower cost and higher performance across a wide range of applications
Today’s press release announcing a line of high-performance remote laser light source products for applications in Cloud-Based Data Centers might very well take POET to a whole new level,
Watch this great first interview of many with
Suresh Venkatesan, Chairman and CEO
Vivek Rajgarhia, President & General Manager
Thomas Mika, Executive Vice President and Chief Financial Officer
Posted by AGORACOM-JC
at 5:51 PM on Tuesday, December 8th, 2020
Awarded the “Solar Impulse Efficient Solution” Label (the “Label”) from the Swiss-based Solar Impulse Foundation (the “Foundation”) for PyroGenesis’ proprietary APT high-powered (“APT-HP”) plasma torch for replacing fossil fuel burners.
The Foundation’s purpose is to identify existing solutions that are both clean, profitable, and having a positive impact on quality of life.
MONTREAL, Dec. 08, 2020 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (OTCQB: PYRNF) (FRA: 8PY), (the “Company”, the “Corporation” or “PyroGenesis”) a Company that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, is pleased to announce today that it has been awarded the “Solar Impulse Efficient Solution” Label (the “Label”) from the Swiss-based Solar Impulse Foundation (the “Foundation”) for PyroGenesis’ proprietary APT high-powered (“APT-HP”) plasma torch for replacing fossil fuel burners. The Foundation’s purpose is to identify existing solutions that are both clean, profitable, and having a positive impact on quality of life.
PyroGenesis’ proprietary APT-HP plasma torch presents an environmentally friendly alternative to fossil fuel burners for use in industrial applications which significantly reduce greenhouse gas emissions. PyroGenesis’ APT-HP can be easily retrofitted into existing installations (such as iron ore furnaces where PyroGenesis has the patent).
To receive this Label, PyroGenesis’ plasma torches went through a rigorous assessment by a group of independent experts who judged PyroGenesis’ proprietary plasma torches against five (5) criteria covering three main topics; Feasibility, Environmental and Profitability. All labelled solutions are part of the #1000solutions portfolio that are to be presented to decision-makers in business and government by Mr. Bertrand Piccard, Chairman of the Solar Impulse Foundation based in Lausanne, Switzerland. The underlying purpose of the Foundation is to encourage the worldwide adoption of more ambitious environmental targets, and thereby fast-tracking the implementation of these solutions on a large scale.
“We are proud to receive this recognition from the Solar Impulse Foundation, which demonstrates PyroGenesis’ emerging leadership role in the reduction of greenhouse gas emissions, specifically as a provider of clean high-powered plasma torches used as a replacement of fossil fuel burners in industrial applications,” said Mr. P. Peter Pascali, CEO and Chair of PyroGenesis. “Having a technological solution labeled by the Foundation not only further validates the value of our high-powered plasma torches as a credible, innovative, profitable and ecological solution, but also provides the Company greater credibility and visibility in the marketplace.”
About the “Solar Impulse Efficient Solution” Label One of the first labels to uniquely identify positive impact technologies which provide solutions to not only protect the environment, but which are also financially viable. The “Solar Impulse Efficient Solution” Label is awarded to companies following a rigorous assessment performed by external independent experts. In collaboration with renowned institutions, solutions applying for the label must go through a validation process based on verified standards. The “Solar Impulse Efficient Solution” Label identifies and serves as an award for clean and profitable environmental solutions.
About Solar Impulse Foundation. The Solar Impulse Foundation aims at selecting 1,000 unique solutions that protect the environment in a profitable way, and award them the Solar Impulse Efficient Solution Label. This label seeks to bridge the gap between ecology and economy, bringing together protection of the environment, and financial viability, while underscoring and emphasizing economical viable solutions to environmental problems, and opportunities for clean economic growth. By selecting 1,000 unique Efficient Solutions, the Solar Impulse Foundation seeks to demonstrate that environmental solutions exist, can create jobs, and generate profit while, at the same time, reducing polluting emissions and preserving natural resources.
AboutPyroGenesisCanada Inc. PyroGenesis Canada Inc., a high-tech company, is a leader in the design, development, manufacture and commercialization of advanced plasma processes and products. The Company provides its engineering and manufacturing expertise and its turnkey process equipment packages to customers in the defense, metallurgical, mining, advanced materials (including 3D printing), and environmental industries. With a team of experienced engineers, scientists and technicians working out of its Montreal office and its 3,800 m 2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. The Company’s core competencies allow PyroGenesis to provide innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. PyroGenesis’ operations are ISO 9001:2015 and AS9100D certified. For more information, please visit www.pyrogenesis.com .
This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject toa number ofrisks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risksdetailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com,or atwww.otcmarkets.com.Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements eitheras a result ofnew information, future events or otherwise, except as required by applicable securities laws.Neither the Toronto Stock Exchange, its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.
SOURCE PyroGenesis Canada Inc.
For further information please contact: Rodayna Kafal, Vice President, IR/Comms. and Strategic BD Phone: (514) 937-0002, E-mail: [email protected]
Posted by AGORACOM-JC
at 5:35 PM on Tuesday, December 8th, 2020
Facebook and other tech giants showed the world that sharing our private data and profiting from it is a major issue. It became such a major issue that sweeping laws have been enacted in Europe (GDPR) and the United States (CCPA) that not only puts a stop to these practices but also demand that individuals are given the opportunity to take control of their digital identities – and even profit from them.
The term is often referred to as “Self Sovereign Identity (SSI)” and though it sounds kind of complicated, it actually sounds like music to the ears of investors that want to learn more about this massive global trend.
KABN is the small cap company that is leaps and bounds ahead of any other small cap company in this space. Their technology is damn cool (check out www.LiquidAvatar.com) and their global recognition is even better given their recent addition to the Trust Over IP Foundation as a Steering Member, joining the likes of IBM, Mastercard, Accenture and other global giants that are forming an ecosystem around SSI
This is a global paradigm shift that you DO NOT want to miss because it is happening right now and KABN is the leading small cap company for investors to gain exposure.
HOW?
KABN Turns The Problem Of Data Privacy Into A Profit For Individuals … and now they are going one step further by enabling healthcare issuers, individuals and verifiers to have a digital COVID-19 verifiable identity healthcare credential that is secure, user managed and controlled to ensure privacy, transportability and ease of use. This solution supports the foundation for the acceptance of digital Healthcare Passports.
Watch this great interview with CEO David Lucatch.
Posted by AGORACOM-JC
at 9:32 AM on Tuesday, December 8th, 2020
Announced marketed public offering of 5,966,900 units of the Company at a price of $0.85 per Unit, for gross proceeds of $5,071,865
Each Unit is comprised of one common share of the Company and one-half of one common share purchase warrant of the Company
Each Warrant is exercisable for one Common Share at a price of $1.20 per share at any time for a period of 36 months following closing of the Offering
TORONTO, ON , Dec. 8, 2020 – Avicanna Inc. (” Avicanna “, or the ” Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) is pleased to announce the closing of its previously announced marketed public offering of 5,966,900 units (the ” Units “) of the Company at a price of $0.85 per Unit, for gross proceeds of $5,071,865 (the ” Offering “). Each Unit is comprised of one common share of the Company (each a ” Common Share “) and one-half of one common share purchase warrant of the Company (each full warrant, a ” Warrant ” and collectively the ” Warrants “). Each Warrant is exercisable for one Common Share at a price of $1.20 per share at any time for a period of 36 months following closing of the Offering.
The Offering was conducted on a “best efforts” basis by a syndicate of agents led by Echelon Wealth Partners Inc., as lead agent and sole-bookrunner, and including Beacon Securities Limited and Canaccord Genuity Corp. (collectively, the ” Agents “).
Aras Azadian , CEO of Avicanna, commented: “The completion of our first prospectus offering and substantial capital raise since our IPO is a confirmation of the on-going support from our existing and new shareholders during a difficult time in the market. This also coincides with further cost reductions and with the launch of our medical products and several other commercial initiatives across several markets where we intend to use the use the proceeds of this raise to pave the way to sustainability and profitability.”
The Company has granted the Agents an option, exercisable in whole or in part, at the sole discretion of the Agents, at any time for a period of 30 days from and including the closing of the Offering, to purchase from the Company up to an additional 15% of the Units sold under the Offering, on the same terms and conditions of the Offering to cover over-allotments, if any, and for market stabilization purposes (the ” Over-Allotment Option “). The Over-Allotment Option may be exercised by the Agents to purchase additional Units, Common Shares, Warrants or any combination thereof.
The Company intends to use the net proceeds of the Offering for product development, working capital and general corporate purposes.
The securities described in this press release have not been and will not be registered under the United States Securities Act of 1933 , as amended (” U.S. Securities Act “) or any state securities laws. Accordingly, the securities may not be offered or sold in the United States (as such term is defined in Regulation S under the U.S. Securities Act) or to, or for the account or benefit of, a U.S. person (as such term is defined in Regulation S under the U.S. Securities Act) except pursuant to transactions exempt from registration under the U.S. Securities Act and under the securities laws of any applicable state. This news release does not constitute an offer to sell or a solicitation of an offer to sell any of securities in the United States .
About Avicanna Inc.
Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development, and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments.
Avicanna is an established leader in cannabinoid research and development, which it primarily conducts at its R&D headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto, Canada and in collaboration with leading Canadian academic and medical institutions. In addition to its developing pharmaceutical pipeline, Avicanna’s team of experts have developed and commercialized several industry leading product lines, including:
Pura H&W™: an advanced and clinically tested line of CBD consumer derma-cosmetic products; and,
RHO Phyto™: an advanced line of medical cannabis products containing varying ratios of CBD and THC currently available nation-wide across Canada in partnership with Medical Cannabis by Shoppers™, a subsidiary of Shoppers Drug Mart. RHO Phyto is the first strictly medical formulary of advanced “Cannabis 2.0” products, containing oils, sprays, capsules, creams, and gels, all 2 developed with scientific rigour, manufactured under GMP standards and supported by pre-clinical data.
With ongoing clinical trials on its derma-cosmetic (Pura H&W), medical cannabis (RHO Phyto) and a pipeline of pharmaceutical products, Avicanna’s dedication to researching the important role that cannabinoids play in an increasingly wider scope of products has been at the core of the Company’s vision since its inception. Furthermore, Avicanna’s commitment to education is demonstrated through its annual medical symposium, the Avicanna Academy educational platform, and the My Cannabis Clinic patient program through its subsidiary company.
Avicanna manages its own supply chain including cultivation and extraction through its two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta , Colombia . Through these sustainable, economical, and industrial scale subsidiaries, Avicanna cultivates, processes, and commercializes a range of cannabis and hemp cultivars dominant in CBD, CBG, THC, and other cannabinoids for use as active pharmaceutical ingredients. Avicanna’s Avesta Genetica program specializes in the development and optimization of rare cultivars for commercial production along with feminized seeds for global export. In June 2020 , Avicanna made history with a shipment of hemp seeds to the United States of America by completing the first ever export of hemp seeds from Colombia .
Stay Connected
For more information about Avicanna, visit www.avicanna.com , call 1-647-243-5283, or contact Setu Purohit , President by email at [email protected] .
Cautionary Note Regarding Forward-Looking Information and Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by the Company, including satisfaction of regulatory requirements in various jurisdictions, exercise of the Over-Allotment Option and the use of proceeds from the Offering.
Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits. Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to current and future market conditions, including the market price of the common shares of the Company, the delay or failure to receive regulatory approvals, and the risk factors set out in the Company’s annual information form dated April 15, 2020 , filed with the Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com .
Posted by AGORACOM-JC
at 9:27 AM on Tuesday, December 8th, 2020
Will be presenting at Alpha Bronze Virtual Town Hall on Wednesday, December 9, 2020 at 12:00 PM EST.
Mr. Bernard Tourillon, Chief Executive Officer of HPQ Silicon, will give an overview of the Company and its growth plan. HPQ Silicon’ objective is to produce high-value speciality Silicon products using new technologies to reduce energy consumption. Mr. Tourillon will respond to Investors questions thereafter.
December 8, 2020 / Alpha Bronze, LLC (“Alpha Bronze”), is pleased to announce that HPQ Silicon Resources Inc. (“HPQ” or “the Company”) (TSXV:HPQ)(OTC PINK:URAGF), a Canadian Innovative Silicon Solutions Provider, will be presenting at Alpha Bronze Virtual Town Hall on Wednesday, December 9, 2020 at 12:00 PM EST.
Mr. Bernard Tourillon, Chief Executive Officer of HPQ Silicon, will give an overview of the Company and its growth plan. HPQ Silicon’ objective is to produce high-value speciality Silicon products using new technologies to reduce energy consumption. Mr. Tourillon will respond to Investors questions thereafter.
HPQ Silicon Resources is a Canadian Innovative Silicon Solutions Provider. Silicon (Si) is one key materials for the decarbonization of the economy and the Renewable Energy Revolution. HPQ is building a portfolio of silicon-based products using innovative, scalable processes. The aim is to produce high-value speciality Silicon products using technologies that will reduce energy consumption, GHG’s, and carbon footprint. Working with PyroGenesis Canada, a high-tech company, HPQ is developing the PUREVAP™ “Quartz Reduction Reactors”, an innovative process, which will permit the one step transformation of quartz (SiO2) into high purity silicon at reduced costs. HPQ Silicon is listed on the TSXV under the symbol “HPQ”. For more information: https://hpqsilicon.com
About Alpha Bronze
Founded in 2013, Alpha Bronze is an investor relations firm based in New York. Alpha Bronze is dedicated to the delivery of top-tier strategic services that encompass IR, capital markets navigation, and corporate communications. The firm has an extensive experience working with emerging growth companies, in the clean-tech, life sciences, consumer and mining sectors. Alpha Bronze’s aim is to increase awareness for its clients among the US investment community. For more info: https://www.alphabronzellc.com
Posted by AGORACOM-JC
at 9:23 AM on Tuesday, December 8th, 2020
Announced today that at the Company’s Board of Directors’ meeting on December 7th, 2020, it was formally approved to move forward with the strategic decision to file an application to list its common shares on the NASDAQ Stock Exchange over the next several days.
NASDAQ is the second largest exchange by market capitalization worldwide, and is home to many of the world’s best technology companies.
Company has engaged Nelson Mullins Riley & Scarborough LLP as its US legal counsel to process the NASDAQ listing, and the Company’s external Canadian legal counsel will provide the required oversight during this process.
PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (OTCQB: PYRNF) (FRA: 8PY), (the “Company”, the “Corporation” or “PyroGenesis”) a Company that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, is pleased to announce today that at the Company’s Board of Directors’ (the “Board”) meeting on December 7th, 2020, it was formally approved to move forward with the strategic decision to file an application to list its common shares (“Shares”) on the NASDAQ Stock Exchange (“NASDAQ”) over the next several days. NASDAQ is the second largest exchange by market capitalization worldwide, and is home to many of the world’s best technology companies.
The Company has engaged Nelson Mullins Riley & Scarborough LLP as its US legal counsel to process the NASDAQ listing, and the Company’s external Canadian legal counsel will provide the required oversight during this process.
“We are pleased to announce today another significant step towards ultimately enhancing shareholder value,” said Mr. P. Peter Pascali, CEO and Chair of PyroGenesis. “The United States has the largest capital market in the world and, as such, a NASDAQ listing has always been on our radar as one of the many strategies to execute as part of our long-term vision for the Company. On the back of our recent achievements, and our successful uplisting to the Toronto Stock Exchange (“TSX”), the Board decided that the timing was right to proceed with this application. After discussions with our US legal counsel, and a representative of NASDAQ, it was confirmed that the Company meets the standard requirements for a listing. However, there still remains a rigorous application procedure which the Company must pass before a final listing is granted. The listing, barring any delays or objections, is expected before the end of Q1 2021.”
There will not be a concurrent financing associated with this listing nor will there be a reverse stock split.
“A NASDAQ listing is a natural next step for the Company,” said Ms. Rodayna Kafal, VP IR/Comms and Strategic BD. “We believe a NASDAQ listing should, amongst other things, (i) provide additional opportunities to attract institutional and retail investors, thus allowing the Company to further broaden its investor base, and (ii) increase the visibility and credibility of the Company worldwide thereby attracting additional sales, partnerships, and M&A opportunities.”
In advance of an anticipated listing on NASDAQ, PyroGenesis will, over the next several days, formally file an application to list on NASDAQ. Shortly thereafter, the Company will file a 40-F registration statement with the United States Securities and Exchange Commission (SEC). The listing of the Company’s Shares on NASDAQ remains subject to the approval of the exchange, and the satisfaction of all applicable listing and regulatory requirements. The Company will continue to maintain the listing of its Shares on the TSX and, subsequent to a successful listing, would trade on both exchanges under the ticker symbol “PYR”.
About PyroGenesis Canada Inc. PyroGenesis Canada Inc., a high-tech company, is a leader in the design, development, manufacture and commercialization of advanced plasma processes and products. The Company provides its engineering and manufacturing expertise and its turnkey process equipment packages to customers in the defense, metallurgical, mining, advanced materials (including 3D printing), and environmental industries. With a team of experienced engineers, scientists and technicians working out of its Montreal office and its 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. The Company’s core competencies allow PyroGenesis to provide innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. PyroGenesis’ operations are ISO 9001:2015 and AS9100D certified. For more information, please visit www.pyrogenesis.com.
This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com.Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws. Neither the Toronto Stock Exchange, its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.
SOURCE PyroGenesis Canada Inc.
For further information please contact: Rodayna Kafal, Vice President, IR/Comms. and Strategic BD Phone: (514) 937-0002, E-mail: [email protected]
Posted by AGORACOM-JC
at 8:12 AM on Tuesday, December 8th, 2020
Verified Self Sovereign Identity, together with a complete end-to-end issuance and verification health credentials ecosystem, ensures individuals have full privacy and control of personal healthcare data, including vaccination records, so they can securely start returning back to public life, freely.
Announced the formation of a consortium of industry leaders that will empower people to start getting back to the activities, people and places they have been missing in their lives.
The consortium has developed an integrated solution that enables healthcare issuers, individuals and verifiers to have a digital COVID-19 verifiable identity healthcare credential that is secure, user managed and controlled to ensure privacy, transportability and ease of use.
This solution supports the foundation for the acceptance of digital Healthcare Passports.
TORONTO, ON and GIBRALTARDecember 8, 2020 / The KABN Network, together with KABN Systems NA Holdings Corp. (CSE:KABN) (the “Company” or “KABN North America”), a Canadian fintech company that specializes in continuous online identity verification, management and monetization in Canada and the US, through its biometrically and identity verified Self Sovereign Identity platform, Liquid Avatar (www.liquidavatar.com), today announces the formation of a consortium of industry leaders that will empower people to start getting back to the activities, people and places they have been missing in their lives. The consortium has developed an integrated solution that enables healthcare issuers, individuals and verifiers to have a digital COVID-19 verifiable identity healthcare credential that is secure, user managed and controlled to ensure privacy, transportability and ease of use. This solution supports the foundation for the acceptance of digital Healthcare Passports.
This consortium initially includes the Lumedic Exchange, to power the healthcare credential ecosystem; Loop Insights (MTRX), a leader in automatic contact tracing; The Campus Agency, to support on campus programs at over 2,000 US Colleges and Universities; and TripXpertz, an organization that works with over 1,000 travel and tourism boards, airlines, wholesalers and resorts, together with Liquid Avatar’s Self Sovereign Identity platform to empower the worldwide Healthcare industry to issue Identity-based Verifiable Credentials through a secure, effective and cost-efficient ecosystem.
This ecosystem will allow qualified Health Professionals with the ability to issue a Verifiable Credential that enables venues and other facilities to verify both the issued credential and the known user in real-time to grant access and / or services. This partnership built on a Trust over IP (TOIP) open standards framework, and the World Wide Web Consortium’s (W3C) specifications for decentralized identifiers for credential management, can power interoperable COVID-19 vaccination and other verifiable credentials across a host of user managed and controlled digital wallets and applications. This process can be used for multiple use cases such as Education, Workplaces, Tradeshows, Healthcare, Sporting Events, Concerts, Entertainment, Travel, Places of Worship, Senior Living, and other facilities, venues and locations and opens the door to further opportunities for commercial and consumer opportunities.
Liquid Avatar’s Self Sovereign Identity (SSI) platform, which includes user biometric validation and a bank-grade verified identity credential, is available to consumers at no cost. Liquid Avatar enables users to verify and manage their identity and access credentials in a cloud-based, biometrically-secure application. Users have complete control over their digital assets (like wallets, passwords and more), identity, and data through easy to use avatars that can be shared, on a permission-basis with others. The COVID-19 Verifiable Healthcare Credential combines healthcare data with the user’s biometrically verified identity credential. When a request is made by a Verifier, the User has a choice of which attributes are shared, creating a private verification transaction between themselves and a verifier. While much of the technology and services are already in place, the launch of the healthcare credential pilot is expected to take place in the first quarter of 2021 to coincide with the expected release of the COVID-19 widespread vaccination program.
This program will not only be able to verify identity credentials for the Covid-19 vaccines, diagnostic and antibody testing, but will also be able to support a wide range of immunizations and healthcare records.
“We want to empower users to return to public life and the things they once did freely, pre-COVID-19, with ease and continued safety, with this and future credentials,” said David Lucatch, CEO of KABN. “Our goal is to help get everyone back to life as efficiently and effectively as possible, so a sense of “normality” can be reestablished. Liquid Avatar and the ecosystem, together with this amazing group and a growing list of partners, will potentially enable businesses, schools, entertainment venues, and more do the normal things that they do and give users the power to engage with them as they did before the pandemic changed our lives.”
Healthcare issuers and individuals will be granted access to the system at no cost. Verifiers wishing to access the system will be charged a nominal subscription and micro-payment per verification, making it very cost efficient and effective to use the system for small and medium sized enterprises all the way up to major airlines, venues and facilities. The partners are committed to making the services affordable to all parties, so that everyone can get back to their everyday lives.
The KABN Network is working with leading industry partners to provide a safe and effective ecosystem that supports the issuance, ownership and verification of these verified identity and access credentials and is proud to be working with the following partners at the outset of this announcement covering a wide range of technologies, issuer, consumer and verification engagement, with additional partners to be named as the program grows.
Trust over IP Foundation (ToIP)
As a member of the Trust over IP Foundation (www.trustoverip.org) steering committee, The KABN Network is committed to the organization’s open-standard framework and tech stacks. ToIP recently released its Covid-19 Credentials Initiative (“CCI”) Governance Framework for public review.
“Trust over IP offers an important new model for how to assemble the pieces that create working and reliable digital trust ecosystems. We are very excited to see momentum growing for real-world cases where the model is being used to make people’s digital lives simpler and better. This includes the KABN Network becoming part of the Lumedic Exchange,” said John Jordan – Executive Director of the Trust over IP Foundation. “We hope to see this momentum continue, and more organizations using the Trust over IP model to create solutions that benefit individuals and businesses.”
Lumedic Exchange
The KABN Network, as a founding partner, is working with the Lumedic Exchange (www.lumedic.io), an open-standards, decentralized framework for the healthcare industry giving patients greater control over their health data.
Chris Ingrao, Chief Strategy Officer of Lumedic, a US-based Health technology company, part of Providence Health Systems ecosystem, comments: “Lumedic recently launched the Lumedic Exchange, the first healthcare ecosystem of its kind dedicated solely to community-driven standards development for patient-intermediated information exchange using verifiable credentials, to support secure exchange of vaccination information.”
Loop Insights, Inc.
Powering professional sports, entertainment, collegiate and other venues and facilities with Automatic Contract Tracing, Loop Insights, Inc. (www.loopinsights.ai) (MTRX) has developed a fully managed contactless check-in platform that securely transfers contact information and triggers real-time notifications at scale.
“The success Loop has had with our recent NCAA sporting events using our venue tracing and management tools, only reinforces the need for a unified verifiable credential that consumers and businesses can trust. Working with KABN and Liquid Avatar and their digital identity platform will provide our customers – and ultimately consumers – with the level of trust required to provide personal information such as COVID testing results, vaccination proof, payment, and other sensitive personal information required in today’s changing landscape. We are thrilled to be one of the first partners to work with KABN and Liquid Avatar on an end to end solution that will provide this safety, security, and peace of mind required to protect consumers looking to return to a new way of life where mobile devices and personal information will be at the forefront of nearly every interaction”, Rob Anson, President and CEO Loop Insights.
The Campus Agency
With reach to over 2,000 US College and University campuses and over 1.5 Million Gen Z students, alumni and families, The Campus Agency (www.thecampusagency.com) has been supporting innovative direct to student and online marketing programs for over 40 years.
“We are really excited to be working with KABN and Liquid Avatar and be a member of this consortium. COVID-19 has impacted the lives of students and faculty on college campuses in such a major way, and we are looking forward to being part of a solution that provides campus communities with the tools and resources they need to return to their way of lives, safely and securely,” Chris Nyland, Chief Operating Officer, The Campus Agency
TripXpertz
Powering over 1,000 travel and government tourism boards, airlines, travel wholesalers and resorts in US, Canada, Mexico, the Caribbean and around the world, to more effectively reach their intended travel audiences with end to end travel marketing management, booking and analytics solutions TripXpertz (www.tripxpertz.com) is changing the way the travel industry reaches travelers and how travelers can receive better value from their travel experiences.
“Our Priority Protection Passport program is aimed at restoring consumer confidence and trust in travelling again and piece-of-mind while away,” says Brad Miron, CEO of TripXpertz. “This partnership gives us, and our multiple program stakeholders, the ability to verify an individual’s identity with certainty, while maintaining security and privacy – In the context of Priority Protection Passport, Liquid Avatar and the capabilities of the Verifiable Identity Healthcare Credentials are foundational to what we must deliver to attract, assure and welcome back tourists to destinations.”
For more information on the program and / or how to become a consortium partner or participant, please visit www.liquidavatar.com
KABN Systems NA Holdings Corp. through its wholly owned subsidiary KABN Systems North America Inc. focuses on the verification, management and monetization of Self Sovereign identity, empowering users to control and benefit from the use of their online identity. The KABN proprietary technology suite includes 4 key products:
Liquid Avatar is a verified Self Sovereign Identity platform empowers users to create high quality digital icons representing their online personas. These icons, in conjunction with KABN ID, allow users to manage and control their digital identity and Verifiable Access and Identity Credentials, and to use Liquid Avatars to share public and permission based private data when they want and with whom they want. www.liquidavatar.com
KABN ID is an Always On, biometric and blockchain based digital identity validation and verification platform allowing users to continuously and confidently prove themselves throughout the online community.
KABN Systems NA Holdings Corp. is publicly listed on the Canadian Securities Exchange (CSE) under the symbol “KABN” (CSE:KABN)
If you have not already joined our mailing list, and would like to receive updates on KABN Systems NA Holdings Corp., please click here to join!
The Trust over IP Foundation is defining a complete architecture for Internet-scale digital trust that combines both cryptographic trust at the machine layer and human trust at the business, legal, and social layers.
Lumedic is a health information logistics company that helps healthcare stakeholders optimally cooperate throughout the administrative ecosystem. The Lumedic platform includes a suite of healthcare interoperability solutions that harmonize action and relieve friction across revenue cycle management, clinical operations, and patient engagement. Lumedic leverages AI, distributed ledgers, design thinking, and open standards to advance the state of healthcare technology and deliver greater health, safety, and wellbeing for patients and communities.
Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia. Loop’s products and services are backed by Amazon’s Partner Network.
With reach to over 2,000 US College and University campuses and over 1.5 Million Gen Z students, alumni and families, The Campus Agency (www.thecampusagency.com) has been supporting innovative direct to student and online marketing programs for over 40 years.
TripXpertz is Toronto-based marketing technology (“MarTech”) company with a 20 year track-record of delivering new monetization paths and superior traveller acquisition and conversion for tourist boards and travel providers globally. The company provides highly targeted, “zero risk”, pay-of-performance campaigns backed by rich engaging destination content that drives awareness and customer conversions at a fraction of industry norm acquisition costs.
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities under the KABN Financing in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
Forward-Looking Information and Statements
This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but is not limited to, information concerning the ability of the Company to generate revenues, roll out new programs and to successfully achieve business objectives, and expectations for other economic, business, and/or competitive factors.
By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.
Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward- looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice.
